help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foidart, J. M.
Right arrow Articles by Liotta, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foidart, J. M.
Right arrow Articles by Liotta, L. A.

American Journal of Pathology, Vol 110, 346-357, Copyright © 1983 by American Society for Investigative Pathology


REGULAR ARTICLES

Abortion in mice induced by intravenous injections of antibodies to type IV collagen or laminin

JM Foidart, M Yaar, A Figueroa, A Wilk, KS Brown and LA Liotta

Purified antibodies to laminin or Type IV collagen administered intravenously to pregnant mice were found to localize in the basement membranes of all maternal tissues as well as the parietal and visceral yolk sacs and trophoblast basement membranes but not in embryonic tissues. Antibodies to Type IV collagen induced a higher incidence of abortions, retroplacental hematomas and fetal deaths. When administered intraamniotically, both antiserums were embryotoxic. The functional consequences of the attachment of antibodies to these specific basement membrane antigens appear to be hemorrhage within the parietal and visceral yolk sacs and separation of fetal from maternal tissues. Complement activation appears to play an important role in the interruptions of pregnancy, because this was not observed in strains of mice lacking C5, the fifth component of complement, in mice depleted of C3 by administration of cobra venom factor, or in mice injected with the F(ab) fragments of antibody to Type IV collagen or laminin.


This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
J. INAGAKI, A. KONDO, L. R. LOPEZ, Y. SHOENFELD, and E. MATSUURA
Pregnancy Loss and Endometriosis: Pathogenic Role of Anti-Laminin-1 Autoantibodies
Ann. N.Y. Acad. Sci., June 1, 2005; 1051(1): 174 - 184.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
Y Shoenfeld and M Blank
Autoantibodies associated with reproductive failure
Lupus, September 1, 2004; 13(9): 643 - 648.
[Abstract] [PDF]


Home page
Hum ReprodHome page
J. Inagaki, M. Sugiura-Ogasawara, M. Nomizu, M. Nakatsuka, K. Ikuta, N. Suzuki, K. Kaihara, K. Kobayashi, T. Yasuda, Y. Shoenfeld, et al.
An association of IgG anti-laminin-1 autoantibodies with endometriosis in infertile patients
Hum. Reprod., March 1, 2003; 18(3): 544 - 549.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. G. Kolonin, R. Pasqualini, and W. Arap
Teratogenicity induced by targeting a placental immunoglobulin transporter
PNAS, October 1, 2002; 99(20): 13055 - 13060.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Society for Investigative Pathology.